Structure of acid phosphatases

Methods in Molecular Biology

Volumn 1053, Issue , 2013, Pages 155-166

  Araujo, César L ^a,b   Vihko, Pirkko T ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Bone resorption; Metallo enzymes; Osteoporosis; Prostate cancer; Tartrate resistant

Indexed keywords

ACID PHOSPHATASE;

AMINO ACID COMPOSITION; ARTICLE; CATALYSIS; CRYSTALLIZATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME STRUCTURE; HYDROLYSIS; IN VITRO STUDY; MOLECULAR WEIGHT; NONHUMAN; NUCLEOPHILICITY; PRIORITY JOURNAL;

ACID PHOSPHATASE; ANIMALS; CATALYSIS; CATALYTIC DOMAIN; GLYCOPROTEINS; HUMANS; ISOENZYMES; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN TYROSINE PHOSPHATASES; RATS; SUBSTRATE SPECIFICITY;

EID: 84881090575     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-562-0_11     Document Type: Article

References (47)

1. Schneider G, Lindqvist Y, Vihko P (1993) Three-dimensional structure of rat acid phosphatase. EMBO J 12:2609-2615
2. Vihko P (1978) Human prostatic acid phosphatase and its radioimmunoassay. Acta Universitatis Ouluensis, Series D Medica 33, Clinica Chemica 1:1-78
3. Van Etten RL (1982) Human prostatic acid phosphatase: A histidine phosphatase. Ann N Y Acad Sci 390:27-51
4. Lindqvist Y, Schneider G, Vihko P (1994) Crystal structures of rat acid phosphatase complexed with the transition-state analogs vanadate and molybdate. Implications for the reaction mechanism. Eur J Biochem 221:139-142
5. Lindqvist Y, Schneider G, Vihko P (1993) Three-dimensional structure of rat acid phosphatase in complex with L(+)-Tartrate. J Biol Chem 268:20744-20746
6. Porvari KS, Herrala AM, Kurkela RM et al (1994) Site-directed mutagenesis of prostatic acid phosphatase. Catalytically important aspartic acid 258, substrate specifi city, and oligomerization. J Biol Chem 269:22642-22646
7. Luchter-Wasylewska E (2001) Cooperative kinetics of human prostatic acid phosphatase. Biochim Biophys Acta 1548:257-264
8. Singh H, Felts RL, Schuermann JP et al (2009) Crystal Structures of the histidine acid phosphatase from Francisella tularensis provide insight into substrate recognition. J Mol Biol 394:893-904
9. Peters C, Geier C, Pohlmann R et al (1989) High degree of homology between primary structure of human lysosomal acid phosphatase and human prostatic acid phosphatase. Biol Chem Hoppe Seyler 370:177-181
10. Pohlmann R, Krentler C, Schmidt B et al (1988) Human lysosomal acid phosphatase: Cloning, expression and chromosomal assignment. EMBO J 7:2343-2350
11. Quintero IB, Araujo CL, Pulkka AE et al (2007) Prostatic acid phosphatase is not a prostate specifi c target. Cancer Res 67:6549-6554
12. Gottschalk S, Waheed A, Schmidt B et al (1989) Sequential processing of lysosomal acid phosphatase by a cytoplasmic thiol proteinase and a lysosomal aspartyl proteinase. EMBO J 8:3215-3219
13. Zylka MJ, Sowa NA, Taylor-Blake B et al (2008) Prostatic acid phosphatase is an ectonucleotidase and suppresses pain by generating adenosine. Neuron 60:111-122
14. Hurt JK, Coleman JL, Fitzpatrick BJ et al (2012) Prostatic acid phosphatase is required for the antinociceptive effects of thiamine and benfotiamine. PLoS One 7:e48562
15. Li HC, Chernoff J, Chen LB et al (1984) A phosphotyrosyl-protein phosphatase activity associated with acid phosphatase from human prostate gland. Eur J Biochem 138:45-51
16. Lin MF, DaVolio J, Garcia-Arenas R (1992) Expression of human prostatic acid phosphatase activity and the growth of prostate carcinoma cells. Cancer Res 52:4600-4607
17. Veeramani S, Chou YW, Lin FC et al (2012) Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells. Free Radic Biol Med 53:95-108
18. Campbell HD, Dionysius DA, Keough DT et al (1978) Iron-containing acid phosphatases: Comparison of the enzymes from beef spleen and pig allantoic fl uid. Biochem Biophys Res Commun 82:615-620
19. Davis JC, Averill BA (1982) Evidence for a spin-coupled binuclear iron unit at the active site of the purple acid phosphatase from beef spleen. Proc Natl Acad Sci USA 79:4623-4627
20. Oddie GW, Schenk G, Angel NZ et al (2000) Structure, function, and regulation of tartrateresistant acid phosphatase. Bone 27:575-584
21. Halleen JM, Raisanen S, Salo JJ et al (1999) Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J Biol Chem 274:22907-22910
22. Antanaitis BC, Aisen P, Lilienthal HR (1983) Physical characterization of two-iron uteroferrin. Evidence for a spin-coupled binuclear iron cluster. J Biol Chem 258:3166-3172
23. Ljusberg J, Ek-Rylander B, Andersson G (1999) Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases. Biochem J 343(Pt 1):63-69
24. Lam WK, Eastlund DT, Li CY et al (1978) Biochemical properties of tartrate-resistant acid phosphatase in serum of adults and children. Clin Chem 24:1105-1108
25. Janckila AJ, Nakasato YR, Neustadt DH et al (2003) Disease-specifi c expression of tartrateresistant acid phosphatase isoforms. J Bone Miner Res 18:1916-1919
26. Andersson G, Lindunger A, Ek-Rylander B (1989) Isolation and characterization of skeletal acid ATPase-A new osteoclast marker? Connect Tissue Res 20:151-158
27. Lam KW, Yam LT (1977) Biochemical characterization of the tartrate-resistant acid phosphatase of human spleen with leukemic reticuloendotheliosis as a pyrophosphatase. Clin Chem 23:89-94
28. Schlosnagle DC, Bazer FW, Tsibris JC et al (1974) An iron-containing phosphatase induced by progesterone in the uterine fl uids of pigs. J Biol Chem 249:7574-7579
29. Hayman AR, Warburton MJ, Pringle JA et al (1989) Purifi cation and characterization of a tartrate-resistant acid phosphatase from human osteoclastomas. Biochem J 261:601-609
30. Lindqvist Y, Johansson E, Kaija H et al (1999) Three-dimensional structure of a mammalian purple acid phosphatase at 2.2 A resolution with a mu-(hydr)oxo bridged di-iron center. J Mol Biol 291:135-147
31. Kaija H (2002) Tartrate-resistant acid phosphatase: Three-dimensional structure and structure-based functional studies. Oulu University Press, Oulu
32. Schenk G, Elliott TW, Leung E et al (2008) Crystal structures of a purple acid phosphatase, representing different steps of this enzyme's catalytic cycle. BMC Struct Biol 8:6
33. Barford D, Das AK, Egloff MP (1998) The structure and mechanism of protein phosphatases: Insights into catalysis and regulation. Annu Rev Biophys Biomol Struct 27:133-164
34. Bull H, Murray PG, Thomas D et al (2002) Acid phosphatases. Mol Pathol 55:65-72
35. Wo YY, McCormack AL, Shabanowitz J et al (1992) Sequencing, cloning, and expression of human red cell-Type acid phosphatase, a cytoplasmic phosphotyrosyl protein phosphatase. J Biol Chem 267:10856-10865
36. Zhang M, Stauffacher CV, Lin D et al (1998) Crystal structure of a human low molecular weight phosphotyrosyl phosphatase. Implications for substrate specifi city. J Biol Chem 273:21714-21720
37. Pandey SK, Yu XX, Watts LM et al (2007) Reduction of low molecular weight proteintyrosine phosphatase expression improves hyperglycemia and insulin sensitivity in obese mice. J Biol Chem 282:14291-14299
38. Chiarugi P, Cirri P, Marra F et al (1997) LMW-PTP is a negative regulator of insulinmediated mitotic and metabolic signalling. Biochem Biophys Res Commun 238:676-682
39. Maccari R, Ottana R, Ciurleo R et al (2009) Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase. ChemMedChem 4:957-962
40. Maccari R, Paoli P, Ottana R et al (2007) 5-Arylidene-2,4- Thiazolidinediones as inhibitors of protein tyrosine phosphatases. Bioorg Med Chem 15:5137-5149
41. Watts NB (2003) Bisphosphonate treatment of osteoporosis. Clin Geriatr Med 19:395-414
42. Abul-Fadl MA, King EJ (1948) The inhibition of acid phosphatases by formaldehyde and its clinical application for the determination of serum acid phosphatases. J Clin Pathol 1:80-90
43. Beers SA, Schwender CF, Loughney DA et al (1996) Phosphatase inhibitors-III. Benzylaminophosphonic acids as potent inhibitors of human prostatic acid phosphatase. Bioorg Med Chem 4:1693-1701
44. Ortlund E, LaCount MW, Lebioda L (2003) Crystal structures of human prostatic acid phosphatase in complex with a phosphate ion and alpha-benzylaminobenzylphosphonic acid update the mechanistic picture and offer new insights into inhibitor design. Biochemistry 42:383-389
45. Abul-Fadl MA, King EJ (1949) Properties of the acid phosphatases of erythrocytes and of the human prostate gland. Biochem J 45:51-60
46. Valcour AA, Bowers GN Jr, McComb RB (1989) Evaluation of a kinetic method for prostatic acid phosphatase with use of self-indicating substrate, 2,6-dichloro-4-nitrophenyl phosphate. Clin Chem 35:939-945
47. Winn SI, Watson HC, Harkins RN et al (1981) Structure and activity of phosphoglycerate mutase. Philos Trans R Soc Lond B Biol Sci 293:121-130